Nutropin (somatropin-rDNA origin)

Company
Genentech

Approval Status
Approved December 1997

Treatment for
growth hormone deficiency

Possible similar drugs
Nutropin

Areas
Diabetes / Endocrinology

The liquid formulation of Nutropin (somatropin injection) has been approved for the replacement of endogenous growth hormone in adult patients with growth hormone deficiency. The product is currently indicated for pediatric growth hormone deficiency and chronic renal insufficiency.

Nutropin_366 Drug Information

The Nutropin_366 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top